The United Kingdom National External Quality Assessment Services (UK NEQAS) for Molecular Genetics provides external quality assessment for a range of inherited diseases and acquired disorders currently tested in diagnostic molecular laboratories.
UK NEQAS for Molecular Genetics gives objective information and advice to clinical laboratories throughout laboratory molecular medicine on the quality of their analytical and interpretative performance, in order to help them provide accurate and reliable test results and advice to clinicians, which facilitates optimal patient care. Advances in our understanding of genetic diseases has led to a revolution in testing technologies. UK NEQAS for Molecular Genetics is committed to providing external quality assessment in this rapidly evolving field.
The Scheme was granted unconditional accreditation by Clinical Pathology Accreditation in January 2001 until March 2016. The Scheme has been granted UK Accreditation Service (UKAS) accredititaion to ISO 17043 in March, 2016 and the scope can be accessed at http://www.ukas.com/wp-content/uploads/schedule_uploads/00013/8505Proficiency%20Testing%20Multiple.pdf
In addition to external quality assessment (EQA) for Molecular Genetics and Molecular Pathology, the Edinburgh centre also provides EQA for Peptide hormones, Tumour markers, Pregnancy testing and Maternal serum screening see http://edqas.org/
NHS Lothian operating UK NEQAS for Molecular Genetics. UK NEQAS for Molecular Genetics is a member of the United Kingdom National External Quality Assessment Service (UK NEQAS), which is a Company Limited by Guarantee (No. 3012351) and a Registered UK Charity (No. 1044013). For more information on the UK NEQAS organisation see www.ukneqas.org.uk